Furthermore, we constructed a TF-mRNA-miRNA regulatory network and explored the contributions of TFs, hub genes and miRNAs to the immune characteristics of MTC and the survival of neuroendocrine tumors, so as to uncover the tumorigenic mechanisms and potential therapeutic targets of MTC. This evidence concerns the gene TF and medullary thyroid gland carcinoma.